Skip to main content
. 2022 Aug 30;21:167. doi: 10.1186/s12933-022-01596-4

Table 2.

SHFS and SHS participant sphingolipid concentrations (µM)

SHFS (n = 597) SHS controls (n = 189) SHS cases (n = 78)
Mean SD Range 90th/10th pct Mean SD Range 90th/10th pct Mean SD Range 90th/10th pct
Cer-16 0.20 0.07 0.06–0.58 2.2 0.32 0.08 0.13–0.64 1.9 0.33 0.09 0.16–0.6 2.2
Cer-20 0.07 0.03 0.01–0.29 2.8 0.11 0.04 0.04–0.38 2.5 0.11 0.04 0.06–0.27 2.2
Cer-22 0.81 0.33 0.23–3.16 2.5 0.76 0.22 0.34–1.84 1.9 0.74 0.22 0.29–1.43 2.1
Cer-24 5.62 2.06 1.75–18.96 2.4 5.15 1.36 2.33–9.94 1.9 5.06 1.41 2.23–9.93 1.9
SM-16 135.21 28.73 59.79–275.51 1.6 131.37 18.38 84.36–186.86 1.4 134.74 25.97 76.13–226.01 1.6
SM-20 20.33 5.00 8.76–44.53 1.9 15.70 3.17 9.17–23.97 1.8 15.15 3.49 6.65–28.98 1.7
SM-22 35.82 9.40 13.09–76.09 1.9 26.21 5.52 14.03–39.15 1.8 25.23 6.06 12.41–48.77 1.8
SM-24 19.36 5.45 7.35–44.67 2.0 14.06 3.36 7.3–23.76 1.8 13.42 3.42 6.46–24.12 1.9